The present invention relates to pharmaceutical compositions comprising achemotactic hematopoietic stem cell product comprising an enriched populationof CD34+ cells containing a subpopulation of cells having chemotacticactivity, methods of preparing these compositions and use of thesecompositions to treat or repair vascular injury, including infarctedmyocardium.